Publications

Search our bibliography using the filters on the right-hand side.

Displaying 101 through 120 of 120 publications.

Pearson IV, Johnson KI. A cost minimization analysis of epoetin zeta for the treatment of anemia associated with chronic kidney disease. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 2008. [abstract] Value Health. 2008 May; 11(3):A304.

Brown TM, Lee WC, Joshi AV, Pashos CL. Health-related quality of life of patients with hemophilia and inhibitors. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 2008. Toronto, Canada. [abstract] Value Health. 2008 May; 11(3):A154.

Jansen JP, Evans CE, Guyot P, Masaquel CJ, Mayne TJ. The impact of epoetin alfa on the symptoms of anemia: a Bayesian meta-analysis of clinical trials. Poster presented at the American Society of Nephrology; November 2007.

Jansen JP, Evans CE, Guyot P, Masaquel CJ, Mayne TJ. The effect of epoetin alfa on physical functioning: a literature review. Poster presented at the American Society of Nephrology Program; November 2007.

Lee WC, Joshi AV, Brown TM, Hadker N, Sumner M, Pashos CL. Physicians' preferences toward coagulation factor concentrates in the treatment of hemophilia patients with inhibitors: a discrete choice experiment. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research; October 2006. [abstract] Value Health. 2006 Nov; 9(6):A251.

Bernardo M, Globe D, Kewalramani R, Masaquel CJ. Costs of anemia management in chronic disease (CKD) from the perspective of the payor, patient, and family. Poster presented at the American Society of Nephrology; November 2006.

Rothman KJ. Thrombosis after travel. PLoS Med. 2006 Aug 22;3(8):e30.

Norgaard M, Larsson H, Pedersen G, Schonheyder HC, Rothman KJ, Sorensen HT. Short-term mortality of bacteraemia in elderly patients with haematological malignancies. Br J Haematol. 2006 Jan 1;132(1):25-31.

Maguire A, Melero-Montes M, Saez-Lloret I, Varas-Lorenzo C, Perez-Gutthann S. Changes in hypokalemia and hyperkalemia between 1991 and 2000 in the US according to hypertensive status and treatment. Poster presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep; 13:S303.

Pladevall-Vila M, Williams K, Guyer H, Sadurni J, Falces C, Ribes A, Pare C, Brotons C, Gabriel R, Serrano-Rios M, Haffner S. The association between leptin and left ventricular hypertrophy: a population-based cross-sectional study. J Hypertens. 2003 Aug;21(8):1467-73.

Arana A, Cid Ruzafa J, Rueda de Castro AM, Warner BA, O'Sullivan D. Evaluation of the clozaril® patient monitoring service (CPMS) in the prevention of clozaril/leponex-induced white-blood-celltoxicity. Presented at the 18th International Conference on Pharmacoepidemiology; August 2002.

Ward A, Caro JJ, Green T, Huybrechts K, Arana A, Wait S, Eleftheriou A. An international survey of patients with thalassemia major and their views about sustaining life-long desferrioxamine use. BMC Clin Pharmacol. 2002;2(3).

Caro JJ, Ward A, Craig T, Huybrecht K, Arana A, Wait S, Eleftheriou A. Impact of thalassemia major on patients and their families. Acta Haematol. 2002;107(3):150-7.

Arboretti R, Tognoni G, Alberti D, Arana A. Pharmacosurveillance and quality of care of thalassaemic patients. A large scale epidemiological survey. Eur J Clin Pharmacol. 2001;56(12):915-22.

Arana A, Wait S, Santamas M, Ward A, Huybrechts K, Craig T. Thalassemia major: geographical variations in prevalence, survival and treatment patterns. Poster presented at the 16th International Conference on Pharmacoepidemiology; August 2000. [abstract] Pharmacoepidemiol Drug Saf. 9(S1):S96.

Anthony M, Clarkson TB. Association between plasma isoflavone and plasma lipoprotein concentrations. J. Med. Food. 1999;2(3-4):263-6.

Blackburn SC, Oliart AD, Garcia Rodriguez LA, Perez GS. Anticonvulsants and blood dyscrasias: a cohort study. Pharmacotherapy. 1998 Nov 1;18(6):1277-83.

Anthony MS, Clarkson TB. Association between plasma isoflavone and plasma lipoprotein concentrations. Presented at the Symposium on Phytoestrogen Research Methods; September 1997. Tucson, AZ.

Martin AV, Coffield K. Hemophilia: information for educators and communication disorders specialists. Poster presented at the American Speech-Language-Hearing Association; April 1997. [abstract] Perspect Lang Learn Educ. 1997 Apr; 4:13-5.